FDA Alerts

Infectious Diseases
Infectious Diseases
08/29/2016
The FDA has issued a revision to their February 2016 guidance for the screening of whole blood and blood components for Zika virus.
08/29/2016
FDA
FDA
08/01/2016
The approval was based on results from a randomized, double-blind, prospective Phase 3 study of 235 pediatric patients.
08/01/2016
FDA Alerts
FDA Alerts
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
07/27/2016
FDA Alerts
FDA Alerts
07/26/2016
The FDA has approved a new treatment option for patients with genotype 1 chronic hepatitis C virus.
07/26/2016
roundup
roundup
07/21/2016
The FDA has approved generic forms of rosuvastatin and a new option for dry eye disease and has heard recommendations to approve a new psoriasis drug.
07/21/2016
FDA
FDA
07/20/2016
The FDA has approved a treatment for hereditary angioedema attacks in pediatric patients.
07/20/2016
FDA Alerts
FDA Alerts
07/19/2016
The FDA has approved a new formulation for lorcaserin HCI for the management of weight in adults.
07/19/2016
FDA Alerts
FDA Alerts
07/13/2016
The FDA has approved the 2016-2017 formulation of Flublok—an egg-free, protein-based vaccine—for prevention of seasonal influenza.
07/13/2016
FDA Alerts
FDA Alerts
06/29/2016